- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 215/40 - Atomes d'azote liés en position 8
Détention brevets de la classe C07D 215/40
Brevets de cette classe: 165
Historique des publications depuis 10 ans
6
|
14
|
10
|
13
|
14
|
16
|
8
|
21
|
10
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
60 Degrees Pharmaceuticals, LLC | 18 |
6 |
The United States of America as represented by the Secretary of the Army | 1195 |
5 |
Glaxo Group Limited | 4496 |
4 |
Incyte Corporation | 918 |
4 |
The Research Foundation for The State University of New York | 1468 |
4 |
Calgent Biotechnology Co., Ltd. | 9 |
4 |
Syngenta Participations AG | 4970 |
3 |
Centre National de La Recherche Scientifique | 9632 |
3 |
National Taiwan University | 1140 |
3 |
Agios Pharmaceuticals, Inc | 200 |
3 |
Guangdong University of Technology | 466 |
3 |
Ontario Institute for Cancer Research (oicr) | 78 |
3 |
Otago Innovation Limited | 55 |
3 |
Rigel Pharmaceuticals, Inc. | 613 |
3 |
The United States Government AS represented by The Department of Veterans Affairs | 949 |
3 |
Pharma Cinq, LLC | 55 |
3 |
ExxonMobil Chemical Patents Inc. | 4286 |
2 |
The Regents of the University of Michigan | 4409 |
2 |
Tsinghua University | 5426 |
2 |
Bioprojet | 52 |
2 |
Autres propriétaires | 100 |